touchONCOLOGY were thrilled to speak to Professor Marcus S Noel (Medstar Georgetown University Hospital, Washington, DC, USA) to summarise the latest developments and data from the ASCO Gastrointestinal Cancers Symposium 2022.
Questions
- Â Â Â What is the rationale for the use of L-asparaginase in the treatment of pancreatic cancer? 00:22-01:00
- Â Â Â Could you give us an overview of the TRYbeCA 1 study? 01:00-02:31
- Â Â Â What were the findings of the KRYSTAL-1 study in FRAS-mutated pancreatic ductal adenocarcinoma? 02:31-03:37
- Â Â Â Following the CISPD3 trial, what is your opinion on the future of PD-1 blockade with chemotherapy in the treatment of pancreatic cancer? 03:47-04:32
Speaker Disclosure: Marcus S Noel has no conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.
Filmed in coverage of the ASCO Gastrointestinal Cancers Symposium 2022.
